Accurate diagnosis and monitoring.
Accurate diagnosis and monitoring.
Undiagnosed, coeliac disease can lead to long-term complications, and as many as 1 in 100 people worldwide are affected by the disease.That’s why we offer clinicians a comprehensive line of test options with QUANTA Lite®, QUANTA Flash®, and NOVA Lite® assays. Our tests include the most clinically relevant biomarkers to ensure accurate diagnosis and follow up testing, which may help patients avoid the long-term complications.
PABRĖŽIA
- Patient care and comfort.With accurate testing, patients can be diagnosed faster and potentially avoid invasive procedures.
- Confident lab technicians.With high-quality tests that correlate with clinical disease parameters, labs can feel confident that they are reporting the most accurate results to clinicians.
- Helping clinicians every step of the way.Using Deamidated Gliadin Peptide (DGP) and human tissue Transglutaminase (htTG) in combination can help stratify patients for biopsy or gluten free diet.
Reagentai
QUANTA Lite® (ELISA)
Aprašymas
Pakuotės dydis
Dalies numeris
Documents
QUANTA Lite® Gliadin IgG II (DGP)
1 X 96 wells
704520
QUANTA Lite® Celiac DGP Screen
1 X 96 wells
704545
QUANTA Lite® Gliadin IgA II (DGP)
1 X 96 wells
704525
QUANTA Flash® (CIA)
Aprašymas
Pakuotės dydis
Dalies numeris
Documents
NOVA Lite® (IFA)
Aprašymas
Pakuotės dydis
Dalies numeris
Documents
NOVA Lite® Monkey Esophagus (IgG and IgA Conjugates)
10 X 5 wells (50 tests)
704145
NOVA Lite® Monkey Esophagus (IgG and IgA conjugates)
25 X 10 wells (250 tests)
704150
